Myalepta 3 mg (Metreleptin POWDER FOR SOLUTION) 3 MG

MYALEPTA 3 MG is a metreleptin powder for subcutaneous solution, used for managing metabolic disorders. This prescription medication supports lipid and glucose metabolism, often in rare conditions. Learn more about its therapeutic uses and effects.

Strength

3 MG

Manufacturer / TM Owner

CHIESI FARMACEUTICI S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MYALEPTA 3 MG, containing metreleptin, is primarily used to manage metabolic disorders. It helps regulate lipid and glucose metabolism, which can be beneficial for individuals with specific metabolic conditions. This medication is often prescribed to support overall metabolic health and balance.

Side Effects

MYALEPTA 3 MG may help improve metabolic functions, including lipid and glucose regulation. Users might experience enhanced metabolic balance, which can contribute to overall well-being. Individual responses can vary, and effects should be monitored by a healthcare professional.

Precautions & Warnings

MYALEPTA 3 MG should be handled with care, following the prescribed guidelines for preparation and administration. It is important to store the medication properly and use it as directed. Always consult a healthcare provider before starting or adjusting any medication regimen.

Avoid Interactions

MYALEPTA 3 MG may interact with other medications, including those that affect metabolism or blood sugar levels. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain dietary supplements may also influence its effects.

Frequently Asked Questions

MYALEPTA 3 MG is used to manage metabolic disorders by supporting lipid and glucose metabolism.

MYALEPTA 3 MG is administered subcutaneously as a solution prepared from the powder.

MYALEPTA 3 MG may help improve metabolic functions, including lipid and glucose regulation.

MYALEPTA 3 MG should be handled and administered as directed by a healthcare professional.

MYALEPTA 3 MG may interact with medications that affect metabolism or blood sugar levels.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.